Related references
Note: Only part of the references are listed.Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders
S. LOIZOU et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
M Samarkos et al.
CLINICAL RHEUMATOLOGY (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia
M Bonomini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome
HB de Laat et al.
BLOOD (2004)
Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
M Galli et al.
BLOOD (2003)
Antiphospholipid thrombosis syndromes
RL Bick
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2001)
Immunoglobulin A anti-β2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death
RM Lee et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
HLA class II alleles associations of anticardiolipin and anti-beta(2)GPI antibodies in a large series of European patients with systemic lupus erythematosus
M Galeazzi et al.
LUPUS (2000)
Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I
TP Greco et al.
LUPUS (2000)
Share Paper
